Literature DB >> 8198542

Regulation of fibrinolysis by non-esterified fatty acids.

A A Higazi1, R Aziza, A A Samara, M Mayer.   

Abstract

The ability of oleic acid to modulate fibrinolysis was measured by following the urokinase-mediated and plasminogen-dependent cleavage of 125I-labelled fibrin clots. Oleic acid levels within the physiological range exerted a concentration-dependent inhibition of urokinase-mediated fibrinolytic activity. SDS/PAGE revealed that oleic acid enhances urokinase activity but simultaneously increases the autolytic cleavage of the newly formed low-molecular-mass subunit of plasmin. Oleic acid-induced cleavage of this subunit containing the catalytic site of plasmin was suppressed by the plasmin substrate H-D-valyl-L-leucyl-L-lysine-p-nitroanilide (S-2251) and was prevented by alpha 2-antiplasmin. A concentration-dependent inhibition of the activity of purified plasmin on 125I-labelled fibrin clot was also observed; 93% and 50% inhibition was noted with 150 microM and 32 microM oleic acid respectively. Oleic acid at 200 microM also effectively displaced plasmin prebound to a polylysine-Sepharose column. Examination of the fatty acid specificity showed that a minimal chain length of 16 carbon atoms and the presence of at least one double bond, preferably in a cis configuration, were required for inhibition of the fibrinolytic activity of plasmin. Oleic acid at a concentration that produced only a minimal inhibition of plasmin activity induced a marked inhibition by palmitic acid, while palmitic acid alone is ineffective. The findings suggest that oleic acid stimulates plasminogen activation and modulates the fibrinolytic and autolytic activities of plasmin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198542      PMCID: PMC1138149          DOI: 10.1042/bj3000251

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid.

Authors:  F B ABLONDI; J J HAGAN; M PHILIPS; E C DE RENZO
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

Review 2.  Thrombolytic therapy in the eighties.

Authors:  M Verstraete; D Collen
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

Review 3.  Biochemical and biological aspects of the plasminogen activation system.

Authors:  M Mayer
Journal:  Clin Biochem       Date:  1990-06       Impact factor: 3.281

4.  On the heterogeneity of activity by various types of plasmins and the spectra of inhibition of some plasmin inhibitors.

Authors:  C M Ambrus; J L Ambrus; H B Lassman; I B Mink
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1970-01

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

7.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

Review 8.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

9.  Stimulation of plasmin activity by oleic acid.

Authors:  A A Higazi; Z Finci-Yeheskel; A A Samara; R Aziza; M Mayer
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

10.  Activation of pro-urokinase by plasmin: non-Michaelian kinetics indicates a mechanism of negative cooperativity.

Authors:  M F Scully; V Ellis; Y Watahiki; V V Kakkar
Journal:  Arch Biochem Biophys       Date:  1989-02-01       Impact factor: 4.013

View more
  5 in total

Review 1.  Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.

Authors:  Chen Zhang; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2009-03-31       Impact factor: 5.118

2.  Fibrinolysis in a lipid environment: modulation through release of free fatty acids.

Authors:  G Rábai; B Váradi; C Longstaff; P Sótonyi; V Kristóf; F Timár; R Machovich; K Kolev
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

Review 3.  Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Med Res Rev       Date:  2014-03-21       Impact factor: 12.944

4.  Suppressed catalytic efficiency of plasmin in the presence of long-chain fatty acids. Identification of kinetic parameters from continuous enzymatic assay with Monte Carlo simulation.

Authors:  Anna Tanka-Salamon; Kiril Tenekedjiev; Raymund Machovich; Krasimir Kolev
Journal:  FEBS J       Date:  2008-02-12       Impact factor: 5.542

5.  Free Fatty Acids Modulate Thrombin Mediated Fibrin Generation Resulting in Less Stable Clots.

Authors:  Anna Tanka-Salamon; Erzsébet Komorowicz; László Szabó; Kiril Tenekedjiev; Krasimir Kolev
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.